Veranderingen in oncologische behandeling van zwangere vrouwen in de afgelopen 20 jaar

Delen via:

Log hier in om volledige toegang te krijgen.

Login of Account maken

 



Bronnen:

  1. de Haan J, Verheecke M, Van Calsteren K, et al. Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients. The Lancet Oncology. 2018;19:337-46.,Amant F, Vandenbroucke T, Verheecke M, et al. Pediatric Outcome after Maternal Cancer Diagnosed during Pregnancy. N Engl J Med. 2015;373:1824-34.,Eibye S, Kjaer SK, Mellemkjaer L. Incidence of pregnancy-associated cancer in Denmark, 1977-2006. Obstet Gynecol. 2013;122:608-17.,Boere I, Lok C, Vandenbroucke T, Amant F. Cancer in pregnancy: safety and efficacy of systemic therapies. Current opinion in oncology. 2017;29:328-34.,Amant F, Halaska MJ, Fumagalli M, et al. Gynecologic cancers in pregnancy: guidelines of a second international consensus meeting. Int J Gynecol Cancer. 2014;24:394-403.,Lavi N, Horowitz NA, Brenner B. An update on the management of hematologic malignancies in pregnancy. Women's health (London, England) 2014;10:255-66.,Amant F, Loibl S, Neven P, Van Calsteren K. Breast cancer in pregnancy. The Lancet. 2012;379:570-9.,Amant F, von Minckwitz G, Han SN, et al. Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study. J Clin Oncol. 2013;31:2532-9.,Fruscio R, de Haan J, Van Calsteren K, Verheecke M, Mhallem M, Amant F. Ovarian cancer in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2016.,Loibl S, Han SN, von Minckwitz G, et al. Treatment of breast cancer during pregnancy: an observational study. The Lancet Oncology. 2012;13:887-96.,Lee AJ, Landau R, Mattingly JL, et al. Left Lateral Table Tilt for Elective Cesarean Delivery under Spinal Anesthesia Has No Effect on Neonatal Acid-Base Status: A Randomized Controlled Trial. Anesthesiology. 2017;127:241-9.,Amant F, Han SN, Gziri MM, Vandenbroucke T, Verheecke M, Van Calsteren K. Management of cancer in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2015;29:741-53.,Yumi H. Guidelines for diagnosis, treatment, and use of laparoscopy for surgical problems during pregnancy: this statement was reviewed and approved by the Board of Governors of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), September 2007. It was prepared by the SAGES Guidelines Committee. Surg Endosc. 2008;22:849-61.,Pearl J, Price R, Richardson W, Fanelli R. Guidelines for diagnosis, treatment, and use of laparoscopy for surgical problems during pregnancy. Surg Endosc. 2011;25:3479-92.,Van Calsteren K, Verbesselt R, Beijnen J, et al. Transplacental transfer of anthracyclines, vinblastine, and 4-hydroxy-cyclophosphamide in a baboon model. Gynecol Oncol. 2010;119:594-600.,Van Calsteren K VR, Devlieger R, et al. Transplacental transfer of paclitaxel, docetaxel, carboplatin, and trastuzumab in a baboon model. Int J Gynecol Cancer. 2010;20:1456-64.,Ngu SF, Ngan HY. Chemotherapy in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2016;33:86-101.,van Hasselt JG vCK, Heyns L, Han S, Mhallem Gziri M, Schellens JH, Beijnen JH, Huitema AD, Amant F. Optimizing anticancer drug treatment in pregnant cancer patients: pharmacokinetic analysis of gestation-induced changes for doxorubicin, epirubicin, docetaxel and paclitaxel. Ann Oncol. 2014;25:2059-65.,Stopenski S, Aslam A, Zhang X, Cardonick E. After Chemotherapy Treatment for Maternal Cancer During Pregnancy, Is Breastfeeding Possible? Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine. 2017;12:91-7.,Mazonakis M, Varveris H, Damilakis J, Theoharopoulos N, Gourtsoyiannis N. Radiation dose to conceptus resulting from tangential breast irradiation. International journal of radiation oncology, biology, physics. 2003;55:386-91.,Toesca A, Gentilini O, Peccatori F, Azim HA, Jr., Amant F. Locoregional treatment of breast cancer during pregnancy. Gynecological surgery. 2014;11:279-84.,Luis SA, Christie DR, Kaminski A, Kenny L, Peres MH. Pregnancy and radiotherapy: management options for minimising risk, case series and comprehensive literature review. J Med Imaging Radiat Oncol. 2009;53:559-68.,Kal HB, Struikmans H. Radiotherapy during pregnancy: fact and fiction. Lancet Oncol. 2005;6:328-33.,Monogr N. National Toxicology Program. NTP Monograph: Developmental Effects and Pregnancy Outcomes Associated With Cancer Chemotherapy Use During Pregnancy. 2013:i-214.,Azim HA, Jr., Metzger-Filho O, de Azambuja E, et al. Pregnancy occurring during or following adjuvant trastuzumab in patients enrolled in the HERA trial (BIG 01-01). Breast cancer research and treatment. 2012;133:387-91.,Zagouri F, Sergentanis TN, Chrysikos D, Papadimitriou CA, Dimopoulos MA, Bartsch R. Trastuzumab administration during pregnancy: a systematic review and meta-analysis. Breast cancer research and treatment. 2013;137:349-57.,Chakravarty EF, Murray ER, Kelman A, Farmer P. Pregnancy outcomes after maternal exposure to rituximab. Blood. 2011;117:1499-506.,Koca E, Kuzan TY, Babacan T, Turkbeyler IH, Furkan S, Altundag K. Safety of tamoxifen during pregnancy: 3 case reports and review of the literature. Breast care (Basel, Switzerland). 2013;8:453-4.,Grunewald S, Jank A. New systemic agents in dermatology with respect to fertility, pregnancy, and lactation. J Dtsch Dermatol Ges. 2015;13:277-89; quiz 90.,Bhandari A, Rolen K, Shah BK. Management of chronic myelogenous leukemia in pregnancy. Anticancer research. 2015;35:1-11.,Amant F, Van Calsteren K, Halaska MJ, et al. Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study. The Lancet Oncology. 2012;13:256-64.,Vandenbroucke T, Verheecke, M, Fumagalli, M, Lok, C, Amant, F. Effects of cancer treatment during pregnancy on fetal and child development. Lancet Child Adolesc Health. 2017;1:302-10.

Doxorubicine-trabectedine met trabectedine-onderhoud bij leiomyosarcoom

nov 2024 | Bot en wekedelentumoren, Gynaecologische oncologie

Lees meer over Doxorubicine-trabectedine met trabectedine-onderhoud bij leiomyosarcoom

Sociaaleconomische verschillen beïnvloeden overleving bij kanker

nov 2024

Lees meer over Sociaaleconomische verschillen beïnvloeden overleving bij kanker

Associatie tussen QoL, effectiviteit en goedkeuring van oncologische geneesmiddelen

nov 2024

Lees meer over Associatie tussen QoL, effectiviteit en goedkeuring van oncologische geneesmiddelen

Speeksel van reptiel brengt alvleeskliertumor in beeld

nov 2024 | Maag-darm-leveroncologie

Lees meer over Speeksel van reptiel brengt alvleeskliertumor in beeld

Ponsegromab voor de behandeling van cachexie bij kanker: een fase II-studie

nov 2024 | Longoncologie, Maag-darm-leveroncologie

Lees meer over Ponsegromab voor de behandeling van cachexie bij kanker: een fase II-studie

Bevolkingsonderzoeken vonden in 2023 bij 27.000 mensen kanker of voorstadia daarvan

nov 2024 | Borstkanker, Gynaecologische oncologie, Maag-darm-leveroncologie

Lees meer over Bevolkingsonderzoeken vonden in 2023 bij 27.000 mensen kanker of voorstadia daarvan

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma

1 okt 2024 om 12:00 | Lymfoom

Lees meer over Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma

Opioïden in de 2e lijn: Sleutels tot effectieve bestrijding van maligne pijn

10 sep 2024 om 20:00

Lees meer over Opioïden in de 2e lijn: Sleutels tot effectieve bestrijding van maligne pijn

Pakketbeslissingen en (on-)zekere kosteneffectiviteit: Willingness to Pay voor geneesmiddelen

1 jul 2024

Lees meer over Pakketbeslissingen en (on-)zekere kosteneffectiviteit: Willingness to Pay voor geneesmiddelen

Challenges in advanced Cutaneous T-cell Lymphoma (CTCL) – diagnosis and management

10 jun 2024 om 16:30 | Lymfoom

Lees meer over Challenges in advanced Cutaneous T-cell Lymphoma (CTCL) – diagnosis and management

Keynote webinar: Spotlight on antibody–drug conjugates in cancer

19 feb 2024 om 17:30 | Borstkanker

Lees meer over Keynote webinar: Spotlight on antibody–drug conjugates in cancer

Prostaatkanker nu en in de toekomst

25 jan 2024 | Uro-oncologie

Lees meer over Prostaatkanker nu en in de toekomst

Niet-melanoom huidkanker in de regio

31 aug 2023 | Dermato-oncologie, Radiotherapie

Lees meer over Niet-melanoom huidkanker in de regio

Keynote Webinar | Spotlight on Cardio-Oncology

16 mei 2023 om 17:30

Lees meer over Keynote Webinar | Spotlight on Cardio-Oncology

Borstkanker; een update op alle vlakken

9 mei 2023 om 20:00 | Borstkanker, Neuro-oncologie

Lees meer over Borstkanker; een update op alle vlakken

Immuno-oncologie module 1: immunologie en immuuntherapie

Lees meer over Immuno-oncologie module 1: immunologie en immuuntherapie

Immuno-oncologie module 2: Bijwerkingenmanagement en checkpoint inhibitors

Lees meer over Immuno-oncologie module 2: Bijwerkingenmanagement en checkpoint inhibitors

Immuno-oncologie module 3: Verpleegkundige casuïstiek

Lees meer over Immuno-oncologie module 3: Verpleegkundige casuïstiek

ASCO Direct™ GU 2025

vrijdag 14 feb 2025 t/m zaterdag 15 feb 2025 | Uro-oncologie

Lees meer over ASCO Direct™ GU 2025

ECCO 2017: Diabetes soms vroeg signaal van pancreascarcinoom

jan 2017 | Maag-darm-leveroncologie

Lees meer over ECCO 2017: Diabetes soms vroeg signaal van pancreascarcinoom

ECCO 2017: Borstsparende operatie soms beter dan borstamputatie

jan 2017 | Borstkanker

Lees meer over ECCO 2017: Borstsparende operatie soms beter dan borstamputatie

ECCO 2017: Kans op cytoreductieve chirurgie plus HIPEC verschilt per ziekenhuis

jan 2017 | Chirurgie, Maag-darm-leveroncologie

Lees meer over ECCO 2017: Kans op cytoreductieve chirurgie plus HIPEC verschilt per ziekenhuis

ECCO 2017: Kwaliteitscontrole van onderzoek met chirurgische component: de CRITICS-studie

jan 2017 | Maag-darm-leveroncologie

Lees meer over ECCO 2017: Kwaliteitscontrole van onderzoek met chirurgische component: de CRITICS-studie

ECCO 2017: Nab-paclitaxel plus gemcitabine bij pancreascarcinoom na adjuvante behandeling

jan 2017 | Maag-darm-leveroncologie

Lees meer over ECCO 2017: Nab-paclitaxel plus gemcitabine bij pancreascarcinoom na adjuvante behandeling

ECCO 2017: Ademanalyse van organische stoffen voor diagnose oesofaguscarcinoom

jan 2017 | Maag-darm-leveroncologie

Lees meer over ECCO 2017: Ademanalyse van organische stoffen voor diagnose oesofaguscarcinoom

ECCO 2017: Eerstelijns-afatinib geeft trend richting betere overleving

jan 2017 | Longoncologie

Lees meer over ECCO 2017: Eerstelijns-afatinib geeft trend richting betere overleving

Ecco 2017: Whole-body diffusion-weighted MRI equivalent aan PET-CT plus hersen-MRI

jan 2017 | Longoncologie

Lees meer over Ecco 2017: Whole-body diffusion-weighted MRI equivalent aan PET-CT plus hersen-MRI

Ecco 2017: Snel herstel QoL na adjuvante 'dose-dense'-chemotherapie

jan 2017 | Borstkanker

Lees meer over Ecco 2017: Snel herstel QoL na adjuvante 'dose-dense'-chemotherapie

Podcast: EGFR ex20ins gemuteerd NSCLC in de dagelijkse klinische praktijk

feb 2024 | Longoncologie

Lees meer over Podcast: EGFR ex20ins gemuteerd NSCLC in de dagelijkse klinische praktijk

Podcast: Progress in PARP inhibitors - An exciting option for treating metastatic prostate cancer?

dec 2023 | Uro-oncologie

Lees meer over Podcast: Progress in PARP inhibitors - An exciting option for treating metastatic prostate cancer?

Podcast pancreascarcinoom

dec 2022 | Maag-darm-leveroncologie

Lees meer over Podcast pancreascarcinoom

Slokdarm- en maagkanker

jun 2021 | Chirurgie, Maag-darm-leveroncologie

Lees meer over Slokdarm- en maagkanker

Impact van COVID-19 op bevolkingsonderzoek darmkanker in Nederland

feb 2021 | Maag-darm-leveroncologie

Lees meer over Impact van COVID-19 op bevolkingsonderzoek darmkanker in Nederland

MedNet Oncologie 2024-05

okt 2024

Lees meer over MedNet Oncologie 2024-05

MedNet Oncologie special Colorectaal carcinoom

sep 2024

Lees meer over MedNet Oncologie special Colorectaal carcinoom

MedNet Oncologie 2024-04

aug 2024

Lees meer over MedNet Oncologie 2024-04

MedNet Oncologie special Borstkanker 2024

jul 2024

Lees meer over MedNet Oncologie special Borstkanker 2024

MedNet Oncologie special Longkanker 2024

jun 2024

Lees meer over MedNet Oncologie special Longkanker 2024

MedNet Oncologie 2024-03

jun 2024

Lees meer over MedNet Oncologie 2024-03

MedNet Oncologie 2024-02

apr 2024

Lees meer over MedNet Oncologie 2024-02

MedNet Oncologie special Uro-Oncologie 2024

mrt 2024

Lees meer over MedNet Oncologie special Uro-Oncologie 2024

MedNet Oncologie 2024-01

feb 2024

Lees meer over MedNet Oncologie 2024-01